PDL BIOPHARMA, INC.·4

Sep 27, 4:42 PM ET

Monnet Dominique 4

4 · PDL BIOPHARMA, INC. · Filed Sep 27, 2018

Insider Transaction Report

Form 4
Period: 2018-09-25
Transactions
  • Award

    Stock Option (right to buy)

    2018-09-25+1,479,9441,479,944 total
    Exercise: $2.52Exp: 2028-09-25Common stock (1,479,944 underlying)
Footnotes (1)
  • [F1]The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.

Documents

1 file
  • 4
    wf-form4_153808091131689.xmlPrimary

    FORM 4